Position in BBIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$126,152,213
+$9,349,842 QoQ
Shares Held
1,693,773
+10.9% QoQ
Ownership
0.866%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 472 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. BBIO ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in BBIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,152,213 | 1,693,773 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $116,802,371 | 1,527,028 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $84,488,319 | 1,956,654 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $43,038,094 | 1,244,955 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $29,236,743 | 1,065,479 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $29,111,778 | 1,143,432 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $22,638,155 | 893,729 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,508,715 | 1,083,723 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $46,843,006 | 1,160,342 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,081,840 | 496,088 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $13,111,663 | 762,306 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $12,639,033 | 762,306 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $7,319,733 | 960,595 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,548,314 | 960,595 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $8,722,202 | 960,595 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $11,103,034 | 1,093,895 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $15,036,936 | 901,495 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $39,053,583 | 833,232 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $50,257,374 | 824,432 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $44,895,866 | 728,829 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $45,011,492 | 632,984 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $21,501,323 | 573,063 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $3,972,452 | 121,817 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $3,532,693 | 121,817 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||